Impact of precision medicine in refractory malignancies

Large disparities found in BCRA testing across ethnicities

Chemotherapy combination with capecitabine extends survival after pancreatic cancer surgery

Primary tumour location in metastatic colorectal cancer impacts overall survival

Temozolomide after radiotherapy improves glioma survival

Relapsed Hodgkin lymphoma in PET positive patients

Entrectinib, a novel treatment for TRK fusions, shows early promise against a range of cancer types

First outcome results from MINDACT breast cancer clinical trial

Genetics may influence risk for breast cancer after chest radiotherapy to treat childhood cancer

A presurgery combination therapy may improve outcomes for women with Her2-positive breast cancer

5 year survival rates for nivolumab-treated metastatic melanoma patients much higher than historical rates

CD4 T-cell immunotherapy targeting MAGE-A3 is safe, and shows early clinical responses